BDCVE-2022-30277CVE-2022-30277
CVSS2
Attack Vector
LOCAL
Attack Complexity
LOW
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
NONE
AV:L/AC:L/Au:N/C:P/I:P/A:N
CVSS3
Attack Vector
PHYSICAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
NONE
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
AI Score
Confidence
High
EPSS
Percentile
12.6%
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
Affected configurations
CNA Affected
[
{
"product": "BD Synapsys™",
"vendor": "Becton Dickinson (BD)",
"versions": [
{
"lessThanOrEqual": "4.30",
"status": "affected",
"version": "4.20",
"versionType": "custom"
}
]
}
]Social References
More
Related
CVSS2
Attack Vector
LOCAL
Attack Complexity
LOW
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
NONE
AV:L/AC:L/Au:N/C:P/I:P/A:N
CVSS3
Attack Vector
PHYSICAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
NONE
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
AI Score
Confidence
High
EPSS
Percentile
12.6%